Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma (Q77392318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

title

Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

anaplastic thyroid carcinoma

1 reference

G Mitchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

R Huddart

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

C Harmer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

33-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used?

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Chemotherapy for thyroid cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Anaplastic giant-cell carcinoma of the thyroid.A study of treatment and prognosis

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. A new approach

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Anaplastic carcinoma of the thyroid gland treated by radiation therapy.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Combination therapy for anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Multimodality treatment in anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Repopulation in human tumors. A biological background for fractionation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Multimodal therapy in anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

Study of cell kinetics in anaplastic thyroid carcinoma transplanted to nude mice

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(98)00102-9

7 January 2021

10.1016/S0167-8140(98)00102-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225555 AND SRC:MED&resulttype=core&format=json

5 December 2019

1 reference